Literature DB >> 11501451

Raloxifene: handle with care.

K I Pritchard, M Levine, B Walley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11501451      PMCID： PMC81279     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.

Authors:  B Fisher; J Dignam; J Bryant; N Wolmark
Journal:  J Natl Cancer Inst       Date:  2001-05-02       Impact factor: 13.506

2.  Phase II evaluation of Ly156758 in metastatic breast cancer.

Authors:  A U Buzdar; C Marcus; F Holmes; V Hug; G Hortobagyi
Journal:  Oncology       Date:  1988       Impact factor: 2.935

3.  Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.

Authors:  M M Gottardis; V C Jordan
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701
  3 in total
  2 in total

1.  Raloxifene and breast cancer.

Authors:  J Lorraine
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 2.  Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.

Authors:  Kathleen I Pritchard; Humaira Khan; Mark Levine
Journal:  CMAJ       Date:  2002-04-16       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.